According to previous studies in other solid cancer forms, TLR9 protein expression has been associated with varying prognosis; in prostate cancer high TLR9 expression has been associated with poor prognosis [29], whereas in breast cancer treated with neoadjuvant chemotherapy, a favorable survival has been indicated [30]. The gene discussed is TLR9; the disease is prostate carcinoma.